AXA S.A. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 214 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
AXA S.A. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$420,680
-26.2%
12,948
-42.8%
0.00%
-50.0%
Q1 2024$569,848
-54.5%
22,622
-63.3%
0.00%
-60.0%
Q4 2022$1,253,127
-4.9%
61,700
+20.0%
0.01%
+66.7%
Q3 2022$1,317,948
-57.1%
51,400
-60.2%
0.00%
-50.0%
Q2 2022$3,071,594
+129.6%
129,150
+117.4%
0.01%
+200.0%
Q1 2022$1,337,844
+128.3%
59,400
+123.3%
0.00%
+100.0%
Q2 2021$586,000
+85.4%
26,600
+100.0%
0.00%0.0%
Q1 2021$316,000
-9.2%
13,3000.0%0.00%0.0%
Q4 2020$348,000
+50.6%
13,3000.0%0.00%0.0%
Q3 2020$231,000
-48.4%
13,300
-50.0%
0.00%0.0%
Q2 2020$448,000
+41.8%
26,6000.0%0.00%0.0%
Q1 2020$316,000
-1.9%
26,6000.0%0.00%0.0%
Q4 2019$322,000
-14.4%
26,6000.0%0.00%0.0%
Q3 2019$376,000
+27.0%
26,6000.0%0.00%0.0%
Q2 2019$296,000
+89.7%
26,600
+100.0%
0.00%0.0%
Q1 2019$156,000
-12.4%
13,3000.0%0.00%0.0%
Q4 2018$178,000
-4.3%
13,3000.0%0.00%0.0%
Q3 2018$186,000
-29.5%
13,300
-20.8%
0.00%0.0%
Q2 2018$264,000
-22.1%
16,800
-18.4%
0.00%0.0%
Q1 2018$339,00020,6000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,360,485$186,0218.91%
Novo Holdings A/S 3,377,768$75,155,3385.81%
Parallel Advisors, LLC 3,726,565$82,916,0712.67%
TANAKA CAPITAL MANAGEMENT INC 35,539$7912.14%
S&T BANK/PA 347,260$7,7271.39%
FAS Wealth Partners, Inc. 310,771$6,914,6550.88%
Birchview Capital, LP 50,000$1,112,5000.83%
Granite Investment Partners, LLC 792,519$17,633,5480.70%
Bridge City Capital, LLC 60,632$1,349,0620.64%
AJ WEALTH STRATEGIES, LLC 509,934$11,346,0320.55%
View complete list of CORCEPT THERAPEUTICS INC shareholders